Pelvic exenteration surgery for advanced pelvic cancers offers a 20% five-year survival rate. This complex procedure is a viable option for localized malignancies, despite a 14% operative mortality.
You might also read
Articles linked to this work by shared authors, journal, and citation graph.
Area of Science:
Background:
Purpose of the Study:
Main Methods:
Main Results:
Conclusions: